Stay updated on Aeterna Zentaris Press Releases

Sign up to get notified when there's something new on the Aeterna Zentaris Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Aeterna Zentaris Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    COSCIENS Biopharma has announced the results of its virtual 2025 meeting of shareholders, replacing the previous corporate update and pipeline prioritization information from December 2024.
    Difference
    13%
    Check dated 2025-07-04T04:21:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    COSCIENS Biopharma Inc. has reconstituted its board to benefit shareholders, with a notable date of May 30, 2025, indicating a strategic shift. The previous report on third quarter 2024 financial results and merger integration has been removed, suggesting a focus on future governance rather than past performance.
    Difference
    17%
    Check dated 2025-06-05T11:25:43.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    COSCIENS Biopharma Inc. has acknowledged receipt of intended director nominations from Goodwood for the upcoming annual and special meeting of shareholders, while a previous announcement regarding a change to the board of directors has been removed.
    Difference
    16%
    Check dated 2025-05-29T06:13:30.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The webpage has been updated to include a report on COSCIENS Biopharma Inc.'s first quarter 2025 financial results and a corporate update, while the announcement of Pierre Labbé's appointment as Director has been removed.
    Difference
    14%
    Check dated 2025-05-15T00:00:14.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    COSCIENS Biopharma Inc. has appointed Anna Biehn as the new CEO and reported its financial results for 2024, while previous updates on merger integration and trial results have been removed.
    Difference
    100%
    Check dated 2025-04-16T13:25:35.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    The webpage has been updated to include a new announcement from COSCIENS Biopharma Inc. regarding a management cease trade order, while the previous financial results report has been removed.
    Difference
    12%
    Check dated 2025-04-09T06:49:43.000Z thumbnail image

Stay in the know with updates to Aeterna Zentaris Press Releases

Enter your email address, and we'll notify you when there's something new on the Aeterna Zentaris Press Releases page.